Mr Stephen Fenwick

Stephen Fenwick qualified in medicine from Nottingham University in 1995, subsequently training in hepatobiliary and liver transplant surgery. For his Doctorate he studied the role of COX-2 in the development of colorectal cancer liver metastases. In 2008 he was appointed Consultant Hepatobiliary Surgeon at Aintree University Hospital in Liverpool, and Honorary Clinical Senior Lecturer at the University of Liverpool. He is the Clinical Lead of the Department of Hepatobiliary Surgery, the Director of the Merseyside and Cheshire Hepatobiliary Cancer Specialist Multi-disciplinary Team, and the Clinical Director of cancer services within his hospital. He is also the associate Clinical Director for cancer within the North West Coast Strategic Clinical Network, and a member of the Cancer Alliance Board.   His major clinical interests include the multi-modal management of advanced colorectal cancer, neuroendocrine tumours, and the management of metastatic ocular melanoma. In 2010 he established the first regional specialist MDT focused on the management of patients with stage 4 CRC. To date he has performed over 700 major liver and biliary resections   His major areas of research interest include 1) the role of exercise intervention prior to major cancer surgery, 2) the mechanisms underlying liver regeneration, 3) culture and bio-engineering of primary hepatocytes and 4) hepatic chemosaturation through isolated percutaneous perfusion. He is an active member of the Liverpool Ocular Oncology Research Group and the governance board of the Liverpool tissue bank.   He was the founding secretary of the Great Britain and Ireland Hepato-Pancreato-Biliary Association (GBIHPBA), and the current Honorary Treasurer of the Association of Upper Gastrointestinal Surgeons (AUGIS). He is a member of the medical advisory board and a trustee of Bowel Cancer UK.

Liver resection surgery Stage 4 Colorectal cancer Gallbladder surgery Neuroendocrine Tumours Metastatic Ocular Melanoma